Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
SUM52PE
HR+
Luminal
JNK-IN-5A
JNK
JNK
11852.144
uM
0.99993
0.73942
-0.0903 0.3895 5.0000 0.2056
0.5793
1.2876
SUM52PE
HR+
Luminal
JNK-IN-5A
JNK
JNK
10695.144
uM
0.40618
0.44426
-0.2818 -0.2826 4.9999 0.5520
0.9957
1.2333
SUM52PE
HR+
Luminal
L-779450
BRAF
MAPK
10695.149
uM
7.51690
13.91570
-0.6803 -1.0000 1.7839 0.2114
0.9575
1.3252
SUM52PE
HR+
Luminal
L-779450
BRAF
MAPK
11852.161
uM
8.98070
16.22710
-0.8083 -1.0000 1.8570 0.2637
0.9662
1.5680
SUM52PE
HR+
Luminal
Lapatinib
EGFR/HER2
ErbB
7541.098
uM
inf
inf
0.7993 0.7993 0.0000 0.1329
0.0794
1.6271
SUM52PE
HR+
Luminal
Lapatinib
EGFR/HER2
ErbB
7539.098
uM
inf
inf
0.8510 0.8510 0.0000 0.1252
0.3898
1.6240
SUM52PE
HR+
Luminal
LBH589
HDAC
HDAC
11852.154
uM
0.08003
0.1480
-0.9211 -0.9089 1.6849 0.7867
0.9986
1.2816
SUM52PE
HR+
Luminal
LBH589
HDAC
HDAC
10695.154
uM
0.26148
0.34978
-0.8474 -0.8430 3.3962 0.6504
0.9991
1.4756
SUM52PE
HR+
Luminal
Lestaurtinib
FLT3/JAK2/TrkA
RTK
10695.154
uM
0.15968
1.18410
-0.9300 -1.0000 0.5483 0.5430
0.9516
1.4756
SUM52PE
HR+
Luminal
Lestaurtinib
FLT3/JAK2/TrkA
RTK
11852.154
uM
0.16629
0.99316
-0.9393 -1.0000 0.6147 0.5442
0.9694
1.2816
SUM52PE
HR+
Luminal
Mebendazole
12969.174
uM
0.22867
0.14055
0.0884 0.2134 1.1431 0.3812
0.9296
1.1194
SUM52PE
HR+
Luminal
Mebendazole
13570.174
uM
0.08562
0.10383
-0.8517 -0.8117 5.0000 0.9710
0.9580
0.5197
SUM52PE
HR+
Luminal
Methotrexate
DHFR
Metabolism
7541.084
uM
inf
inf
0.9224 0.9224 0.0000 0.0098
0.2324
1.2092
SUM52PE
HR+
Luminal
Methylglyoxal
13651.184
uM
inf
inf
-0.6727 -0.6727 0.0000 0.8697
0.5569
0.7406
SUM52PE
HR+
Luminal
MG-132
Proteasome
Proteasome
14290.189
uM
0.10536
0.12055
-0.7967 -0.4805 5.0000 0.7678
0.8845
0.5261
SUM52PE
HR+
Luminal
MG-132
Proteasome
Proteasome
14290.189
uM
0.10536
0.12055
-0.7967 -0.4805 5.0000 0.7678
0.8845
0.5261
SUM52PE
HR+
Luminal
MG-132
Proteasome
Proteasome
11852.145
uM
0.07167
0.08515
-0.7150 -0.6832 5.0000 0.8905
0.9965
1.5550
SUM52PE
HR+
Luminal
MG-132
Proteasome
Proteasome
11852.145
uM
0.07167
0.08515
-0.7150 -0.6832 5.0000 0.8905
0.9965
1.5550
SUM52PE
HR+
Luminal
MG-132
Proteasome
Proteasome
10695.145
uM
0.07446
0.09028
-0.8612 -0.8103 5.0000 0.9308
0.9967
1.1360
SUM52PE
HR+
Luminal
MG-132
Proteasome
Proteasome
10695.145
uM
0.07446
0.09028
-0.8612 -0.8103 5.0000 0.9308
0.9967
1.1360
SUM52PE
HR+
Luminal
Pevonedistat
NAE1
NAE1
10695.148
uM
0.22871
0.60119
0.0411 -0.2086 0.3608 0.4862
0.9139
1.5078
SUM52PE
HR+
Luminal
Pevonedistat
NAE1
NAE1
11852.135
uM
0.51894
0.64597
-0.4142 -0.2919 2.1000 0.4515
0.9890
1.2467
SUM52PE
HR+
Luminal
Nelfinavir
13570.174
uM
inf
inf
0.3681 0.3681 0.0000 0.1153
0.4883
0.5197
SUM52PE
HR+
Luminal
Nelfinavir
12969.174
uM
8.40510
18.55740
-0.4010 -1.0000 1.3871 0.2195
0.9278
1.1194
SUM52PE
HR+
Luminal
Nilotinib
ABL
nRTK
11852.145
uM
inf
inf
1.0081 1.0081 0.0000 0.0183
0.1759
1.5550